John D Diekman's Net Worth
$179 Million
Who is John D Diekman?
John D Diekman has an estimated net worth of $179 Million. This is based on reported shares across multiple companies, which include Skye Bioscience, Inc., Zai Lab Ltd, Crinetics Pharmaceuticals, Inc., Pear Therapeutics, Inc., IDEAYA Biosciences, Inc., ARVINAS, INC., Cidara Therapeutics, Inc., VIVEVE MEDICAL, INC., scPharmaceuticals Inc., Homology Medicines, Inc., Aprea Therapeutics, Inc., Audentes Therapeutics, Inc., PHASERX, INC., EPIRUS Biopharmaceuticals, Inc., and AFFYMETRIX INC.
SEC CIK
John D Diekman's CIK is 0001240357
Past Insider Trading and Trends
2019 was John D Diekman's most active year for acquiring shares with 26 total transactions. John D Diekman's most active month to acquire stocks was the month of January. 2022 was John D Diekman's most active year for disposing of shares, totalling 46 transactions. John D Diekman's most active month to dispose stocks was the month of October. 2024 saw John D Diekman paying a total of $12,026,030.94 for 5,206,074 shares, this is the most they've acquired in one year. In 2019 John D Diekman cashed out on 8,470,662 shares for a total of $54,804,484.83, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Skye Bioscience, Inc. (SKYE) Snapshot price: $4.8975
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +5.66% | 450K |
$10.00 | $4,500,000.00 | 8.39M |
Mar 13
| |||
Form 4
| +190.18% | 5.21M |
$2.31 | $12,026,030.94 | 7.94M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Crinetics Pharmaceuticals, Inc. (CRNX) Snapshot price: $37.675
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -9.57% | -250.00K |
$22.20 | -$5,550,000.00 | 2.36M |
Jun 21
| |||
Form 4
| -5.60% | -154.84K |
$24.25 | -$3,754,954.14 | 2.61M |
Mar 18
| |||
Form 4
| -14.35% | -464.83K |
—
|
—
| 2.77M |
Feb 20
| |||
Form 4
| -7.49% | -262.15K |
$21.88 | -$5,734,596.87 | 3.24M |
Jan 22
| |||
Form 4
| +103.40% | 3.5M |
$17.00 | $1,955,000.00 | 6.88M |
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pear Therapeutics, Inc. (PEARQ) Snapshot price: $0.0002
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -98.81% | -16.54M |
$0.12 | -$1,985,293.56 | 200K |
Apr 10
| |||
Form 4
| -0.78% | -105.28K |
$2.74 | -$288,267.28 | 13.37M |
Nov 11 - Nov 15
| |||
Form 4
| -0.40% | -54.21K |
$2.77 | -$150,095.68 | 13.48M |
Oct 31 - Nov 2
| |||
Form 4
| -3.96% | -558.17K |
$1.88 | -$1,047,321.73 | 13.53M |
Sep 14 - Sep 16
| |||
Form 4
| -5.18% | -770.00K |
$2.05 | -$1,581,834.98 | 14.09M |
Sep 6 - Sep 8
| |||
Form 4
| -2.62% | -400.00K |
$1.65 | -$660,059.58 | 14.86M |
Aug 16 - Aug 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ARVINAS, INC. (ARVN) Snapshot price: $47.92
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.61% | -312.36K |
—
|
—
| 3.3M |
Sep 16
| |||
Form 4
| -9.61% | -810.00K |
$21.89 | -$17,714,700.00 | 7.62M |
Jun 27 - Jun 28
| |||
Form 4
| -4.11% | -190.00K |
$19.65 | -$3,733,500.00 | 4.44M |
Jun 7
| |||
Form 4
| -7.24% | -361.13K |
$14.16 | -$5,112,683.82 | 4.63M |
Mar 28
| |||
Form 4
|
∞
| 4.99M |
—
|
—
| 4.99M |
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Cidara Therapeutics, Inc. (CDTX) Snapshot price: $0.6601
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +919.31% | 1.81M |
—
|
—
| 2.01M |
Apr 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |